NCT06347445 (TEMD-2) is a clinical trial of There is no intervention. in Diabetes Mellitus, sponsored by Gulhane School of Medicine.

Who is sponsoring NCT06347445?

NCT06347445 is sponsored by Gulhane School of Medicine.

What drugs are being tested in NCT06347445?

Interventions in NCT06347445: There is no intervention..

What condition does NCT06347445 study?

NCT06347445 studies Diabetes Mellitus.

Is NCT06347445 still recruiting?

NCT06347445 is currently completed. Last updated 4 April 2024.

Last reviewed 2024-04-04 · How we verify

NCT06347445: TEMD-2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study)

Completed Last updated 4 April 2024

What this trial tests

trial testing There is no intervention. in Diabetes Mellitus in 5,707 participants. Completed in 30 January 2023.

Timeline

1 October 2022

Primary endpoint
30 January 2023

30 January 2023

Quick facts

Lead sponsor	Gulhane School of Medicine
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5,707
Start date	1 October 2022
Primary completion	30 January 2023
Estimated completion	30 January 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

There is no intervention.

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Gulhane School of Medicine

Who can join

18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the metabolic control status, cardiovascular risk and frequency of comorbidities in diabetic patients followed in tertiary treatment centers in Turkey.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Polypharmacy and associated factors in patients with type 2 diabetes: a nationwide cross-sectional study (TEMD-2 polypharmacy study).
Şah Ünal FT, Gökçay Canpolat A, Emral R, Haymana C, et al · · 2026 · PMID 42130190 · DOI 10.1080/00325481.2026.2673267
Impact of Obesity on Metabolic Control in Type 2 Diabetes: Five-Year Trends of Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes (TEMD Obesity Study, 2017-2022).
Kiyici S, Demirci I, Sonmez A, Haymana C, et al · · 2026 · PMID 40582352 · DOI 10.1159/000547136

Verify or expand the search:

Other trials of There is no intervention.

Trials testing the same drug.

NCT07393841 — Molecular Indicators of Systematic Fitness · recruiting
NCT06113601 — Assessment of Admission to the ICU of Onco-hematological Patients. · unknown
NCT06016309 — The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis · recruiting
NCT04804995 — Investigating the Frequency and Phenotype of Headaches Associated With Fasting During the Month of Ramadan. · completed
NCT04160585 — Individual and Work-Related Risk Factors for Musculoskeletal Pain: a Cross-Sectional Study Among Turkish Office Workers · completed

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other Gulhane School of Medicine trials

Trials by the same sponsor.

NCT07383987 — Genital Hygiene, Toilet Behaviors, and LUTS in Normal Weight and Obese Women · recruiting
NCT07356401 — Associations of Cranial Outcomes and Parental Expectations and Satisfaction · recruiting
NCT07374237 — Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients W · completed
NCT07347561 — A Comparison of Myoelectric and Bionic Hands · recruiting
NCT06850428 — Examining the Relationship Between Physical Activity Levels and Chronotype Tendencies in Individuals With Alcohol Depend · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06347445 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gulhane School of Medicine
Last refreshed: 4 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06347445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing